![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
An Interferon-Free, Ribavirin-Free 12-Week Regimen of Daclatasvir (DCV), Asunaprevir (ASV), and BMS-791325 Yielded SVR4 of 94% in Treatment-Naïve Patients with Genotype (GT) 1 Chronic Hepatitis C Virus (HCV) Infection
|
|
|
Reported by Jules Levin
AASLD 2012 Nov 9-13 Boston
Everson GT, Sims KD, Rodriguez-Torres M, Hezode C, Lawitz E, Bourlière M, Loustaud-Ratti V, Rustgi V, Schwartz H, Tatum H, Marcellin P, Pol S, Thuluvath PJ, Eley T, Wang X, Huang SP, McPhee F, Wind-Rotolo M, Chung E, Pasquinelli C, Grasela DM, Gardiner DF
![AASLD1.gif](../images/111312/111312-7/AASLD1.gif)
![AASLD2.gif](../images/111312/111312-7/AASLD2.gif)
![AASLD3.gif](../images/111312/111312-7/AASLD3.gif)
![AASLD4.gif](../images/111312/111312-7/AASLD4.gif)
![AASLD5.gif](../images/111312/111312-7/AASLD5.gif)
![AASLD6.gif](../images/111312/111312-7/AASLD6.gif)
![AASLD7.gif](../images/111312/111312-7/AASLD7.gif)
![AASLD8.gif](../images/111312/111312-7/AASLD8.gif)
![AASLD9.gif](../images/111312/111312-7/AASLD9.gif)
![AASLD10.gif](../images/111312/111312-7/AASLD10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|